Peritoneal dialysis in children undergoing congenital cardiac surgery under three years of age Anah tar söz cük ler: Akut böbrek yetmezliği; doğuştan kalp cerrahisi; pediyatrik hasta; periton diyalizi.
Acute renal failure (ARF) affects over 10% of children who undergo cardiopulmonary bypass (CPB). [1] [2] [3] Despite progress in cardiac surgery and intensive care techniques, the mortality rate still remains high (ranging from 20 to 79%) in this group of patients. [2, 4] Peritoneal dialysis (PD) is the most widely available form of renal replacement therapy used in neonates, infants, and children. [5, 6] The possible advantages and potential limitations of PD should be considered in the management of patients with ARF.
In this study, we aimed to investigate the incidence, risk factors, and outcomes of PD in children and to evaluate the effect of PD on morbidity and mortality rates undergoing congenital cardiac surgery under three years of age.
PATIENTS AND METHODS
The hospital records of a total of 36 patients who underwent open heart surgery for congenital heart disease and PD between December 2007 and April 2013 were retrospectively analyzed.
Exclusion criteria were as follows: PD for less than one day (n=1), previous renal insufficiency (loss of kidney function, n=2), or incomplete data (n=2). Three patients who died within 72 hours after congenital cardiac surgery were also excluded from the study.
Demographic data of the patients, cardiac diagnoses, perioperative data, and outcomes were collected. Physiological variables including blood urea nitrogen (BUN) and serum creatinine before the initiation of PD and after the end of PD, preoperative mechanical ventilatory support, presence of syndrome disorders, indications and complications of dialysis, timing of PD catheter insertion, time from surgery to PD, and duration of PD were also recorded. Surgical complexity was assessed by the Risk Adjustment for Congenital Heart Surgery (RACHS-1) risk categories (range, 1 to 6). [7] Renal function prior to PD catheter placement was assessed according to the PediatricModified Risk of renal failure, Injury to the kidney, Failure of kidney function, Loss of kidney function, and End-stage renal failure (pRIFLE) criteria. [8] The patients with a RIFLE score were included; however, patients whose PD catheters were placed preoperatively due to the loss of kindey function and end-stage kidney disease were excluded. The inotropic score (IS) [9] and vasoactive-inotropic score (VIS) [10] were also calculated.
IS=Dopamine (μg/kg/min) + dobutamine (μg/kg/min) + 100 × epinephrine (μg/kg/min), VIS= IS + 10 x milrinone dose (μg/kg/min) + 10,000 x vasopressin dose (U/kg/min) + 100 x norepinephrine dose (μg/kg/min). In addition, the mean arterial blood pressure (MAP), central venous blood pressure (CVP), perioperative urine output, fluid balance before initiation of PD, diuresis after PD, intensive care unit (ICU), and length of hospital stay (LOS) were obtained from the medical records.
A peritoneal catheter was inserted percutaneously through a paraumbilical left-sided approach in the intensive care unit at the bedside using general anesthesia. The semi-rigid catheter inserted using a trocar was the most commonly used catheter. We used a closed irrigation/drainage system in all patients. Dialysis solution was a potassium-free bicarbonate solution containing variable glucose concentrations. The dextrose concentration varied from 1.5 to 4.5% and the choice of dextrose concentration depended on the presence of serum hyperglycemia. Dialysis was initiated with a 1.5 g/dL solution. Then, PD was started with a dwell volume of 10 mL/kg, a dextrose concentration of 1.5%, a fill time of 10 minutes, a dwell time of 30 minutes, and a drainage time of 20 minutes. The dwell time varied from 1 to 2 hours. The cycle length and dialysis solution were adapted to the clinical and biochemical status of the patient. Trained nurses changed the dialysate bags every 24 hours.
The recovery of the urine output was defined as a urine output >1 mL/kg/hour, and the recovery of serum creatinine was defined as a decline in serum creatinine to preoperative levels. Indications for terminating PD included the return of sufficient of urine output to maintain or achieve negative fluid balance and normalization of serum electrolytes and acid-base status.
The study protocol was approved by the local Ethics Committee. The study was conducted in accordance with the principles of the Declaration of Helsinki.
Statistical analysis
Statistical analysis was performed using IBM SPSS version 22.0 for Windows software (IBM Corporation, Armonk, NY, USA). Data were expressed in the mean ± standard deviation or median (range). Univariate analysis was performed to compare the demographic data. The distribution of variables was analyzed by the Kolmogorov-Smirnov test. The chi-square and Fisher's exact tests were used to compare categorical variables between the groups. Continuous variables between groups were assessed using the Mann-Whitney U-test. Non-conditional logistic regression was used to explore the associated risk factors of recovery of renal function and survey. A p value less than 0.05 was considered statistically significant.
RESULTS
The type of congenital heart defect and operation are shown in Table 1 . The median age of the patients at surgery was 10.1 months (range, 0.1 to 36 months) with a median body weight of 6.7 kg (range, 3 to 12.5 kg). Recovery of renal function was reported in 18 patients (50%). The median RACHS-1 score was 3. There was no significant difference in the RIFLE categories between survivors/non-survivors and recovery/nonrecovery groups (p= 0.317 and p= 0.371, respectively). The pRIFLE categories are shown in Table 2 . These findings showed that the pRIFLE-based renal function was not related to postoperative complications.
Mortality was 72.2% (n=26). Among the total of 26 patients, eight patients (44.4%) were in recovery of renal function group and 18 patients were in (100%) non-recovery of renal function group. In-hospital mortality is presented in Table 2 . The causes of death were pump failure in 13 (congestive heart failure or extensive myocardial injury), sepsis in five (pneumonia in four and PD-associated peritonitis in one), arrhythmia in two, pulmonary hypertension crisis in two, sudden cardiac arrest without obvious cause in two, pulmonary hemorrhage in one, and cerebral hemorrhage in one. Furthermore, the survivors had a higher mean MAP (50.5±5.1 vs 60±7.6 mmHg, p= 0.036), lower mean CVP (14.6±2.2 vs 11±2 mmHg, p= 0.045), higher perioperative urine output (6.8±4.5 vs 4.0±2.7 mL/kg/h, p= 0.022), and higher diuresis after PD (1.6±0.2 vs 0.4±0.6 mL/kg/h, p<0.001) than non-survivors. Additionally, lower pre-PD BUN and serum creatinine values, lower time interval between surgery and PD and lower fluid balance before PD were associated with survival.
According to logistic regression analysis, the following factors were found to be independently associated with survey: perioperative urine output [odds ratio (OR)= 0.818; 95% confidence interval (CI)= 0. (Table 5 ).
In addition, as shown in Table 6 , time interval between surgery and PD, mean MAP before PD, mean inotropic score onset of PD, mean VIS onset of PD, ICU LOS and hospital LOS contributed as the independent risk factors for recovery of renal function (p<0.05).
DISCUSSION
Acute renal failure is common in pediatrics undergoing complex congenital cardiac surgery. However, the use of renal replacement therapy (RRT) in this patients may vary among adults due to associated conditions causing ARF, variable patient weights, [11] and nonrenal indications for RRT such as the postoperative period of patients with congenital heart defects. [12] Peritoneal dialysis is the first-line RRT modality which is relatively easy to employ, effective, and has a low complication rate to be used for ARF in these patients. [1, 4, 13, 14] Several studies have attempted to identify the risk factors of ARF requiring RRT in pediatric patients undergoing congenital cardiac surgery. [2, 7, 14] In consistent with previous studies, [15] [16] [17] patients who showed recovery of renal function following PD with associated lower CPB and CC times, RACHS-1 category and inotrope scores, BUN and SCr values before PD and a lower time interval between surgery and PD had lower mortality. Additionally, in the present study, higher MAP and CVP scores before PD, late beginning of PD, lower perioperative urine output, and lower diuresis after PD were significant risk factors for increased mortality. A higher RACHS-1 category was significantly associated with the development of ARF and higher mortality rates. [18] We also confirmed that the RACHS-1 score and complexity of surgery associated with it was a significant risk factor. We also demonstrated that increasing mortality and failure of PD was associated with lower MAP and higher CVP before PD. Analysis of these risk factors can reduce mortality and morbidity. Furthermore, with appropriate assessment of these factors will lead to a better outcome of PD in postoperative period. This may be due to lower time interval between surgery and PD in the recovery and survivor groups, whereas most other groups started PD later. [2, 4] In the current study, the renal function normalized after PD in all surviving patients, and this rate was in consistent with the previous studies.
[ 1, 19] In addition, the incidence of postoperative ARF can be as high as 42% with an incidence of 1 to 17% for dialysis and a mortality rate of 20 to 100%. [12, 15, 16, 19, 20] The incidence of ARF, which required PD and mortality rate following congenital cardiac surgery in our study population, were 7.9% and 72.2%, respectively. The development of ARF is often related to the results of CPB with the associated complexity of the operation (RACHS-1 category) in pediatric patients. [15] Patients with non-recovery of renal functions after PD still have a higher mortality than patients with recovery of renal function. The mortality rate was 44.4% (n=8) in 18 patients with recovery of renal function and 100% in 18 patients without recovery of renal function. Our study also demonstrated an association between more complex surgical procedures as defined by higher RACHS-1 scores and higher mortality rates in patients with postoperative PD who underwent congenital heart surgery. These patients had significantly higher RACHS-1 scores, longer CPB time, cross-clamp time, and ICU and hospital LOS. In the light of these findings, we can conclude that ARF constitutes an important predictor of mortality and morbidity. Despite improved renal functions, a significant number of these patients with of ARF supported by RRT still dies.
In the present study, the main factor of mortality in the patients with recovery of renal function was the presence of sepsis. The mortality-related factors may be directly linked to sepsis associated with ICU problems, such as ventilator-associated pneumonia. [21] Mortality was found to be significantly increased in patients with sepsis associated with prolonged ICU stay in the present study. The mortality rate associated with sepsis was 50% (n=4) in eight patients with recovery of renal function and 5.5% (n=1) in 18 patients without recovery of renal function.
As the rate of PD peritonitis decreases, noninfectious complications of PD are proportionately increasing. [22] What is emerging, as an important cause of technical failure, is mechanical catheter complications. To reduce the risk of hyperglycemia, hyperinsulinemia and hyperleptinemia, the metabolic complications of PD and glucose-sparing strategies have also started to increasingly draw attention. [23] However, it should be kept in mind that complications which are associated with morbidity and technical failure can be prevented, recognized beforehand, and appropriately managed. [22, 23] Optimal timing and the criteria indicating PD are still controversial issues on debate. In some centers, peritoneal catheters are prophylactically placed in infants who are at a high risk of ARF and CPB following surgery, whereas these catheters are used by other centers, including ours, to serve as a continuous drain of the abdominal cavity, for the dialysis of persistent low urinary output, to correct electrolytes and metabolic status, or to remove fluid. [1] In a study conducted by Dittrich et al., [24] in which the prophylactic and early use of PD was applied in the presence of risk factors for ARF, improved control of fluid balance and a more favorable patient outcomes with a mortality rate of 27% were reported.
The usual indications for the initiation of RRT in patients with acute kidney injury (AKI) include oliguria/anuria leading to refractory fluid overload, metabolic abnormalities such as hyperkalemia (K+>6.5 mEq/L) and severe metabolic acidosis (pH<7.1). [25] We introduced PD, if the patient had risk factors for ARF, based on the RIFLE criteria. Tables 1 and 2 show the indications for PD and RIFLE categories. However, the adverse effects of fluid overload on the outcome of children with AKI were observed. [26] Fluid overload is also associated with a reduced likelihood of recovery of renal functions. [27] In the survivor group, fluid balance and mean CVP before PD was lower than in the non-survivors. Although there are large-scale retrospective reports on the timing of PD initiation, no criteria have been established from randomized-controlled trials, but rather based on historically held beliefs and practices of medical personnel worldwide. [28] In the present study, the time of beginning PD in the survivors and recovery of the renal function group was significantly earlier than non-survivors and non-recovery of the renal function group. This modality does not require anticoagulation and is ideal for neonates, children with inadequate vascular access, and those who can tolerate slower fluid removal and electrolyte correction. The benefits of PD include ease and quickness of the catheter insertion, costefficacy compared to other modalities, and overall tolerance for the hemodynamic stability. [5] However, the increased risk of complications such as gastrointestinal perforation, peritonitis, catheter malfunction, and poor dialysate flow are the main limitations. [6] In pediatric patients, the rate of peritonitis is approximately one episode of peritonitis per catheter-year. [29] In the present study, primary peritonitis developed in only one patient (2.7%), and the complication rate is consistent with the previous studies. [1, 24] Nonetheless, our study has some limitations. The primary limitation was its small sample size and retrospective design. In addition, the RACHS score and indication of PD were unable to be standardized. Despite these drawbacks, we still believe that our findings were relevant.
In conclusion, despite the fact that peritoneal dialysis is an important renal replacement therapy modality for acute renal failure following cardiac surgery in young children, these patients are high-risk population with an in-hospital mortality of 72.2%. For such high-risk patients with possible detrimental effects of acute renal failure, peritoneal dialysis is effective and useful to achieve postoperative negative fluid balance and produce hemodynamic stability. In patients requiring peritoneal dialysis, preoperative, intraoperative, and postoperative cardiopulmonary status have a significant bearing on the total duration of peritoneal dialysis, mortality, and morbidity. Our study results showed that cardiopulmonary bypass and cross-clamp time, low cardiac output syndrome, time interval between surgery and peritoneal dialysis, fluid balance before peritoneal dialysis and peritoneal dialysis-related complications were the determinant factors for the prognosis of peritoneal dialysis in pediatric patients aged three years and below with acute renal failure undergoing congenital heart surgery. Furthermore, we found that higher inotrope scores, lower mean arterial blood pressure, and higher central venous blood pressure were associated with an increased morbidity and mortality. Although peritoneal dialysis is considered an optimal therapy for the management of acute renal failure, recovery of the renal functions alone may not be sufficient in these patients for survival. In addition, as the management of peritoneal dialysis in pediatric congenital cardiac surgery is complex, there are various demographics, intraoperative, and postoperative factors which contribute to clinical outcomes. Despite some of these factors are inclusive to the complex congenital cardiac surgery, early peritoneal dialysis administration is the most important part of the process to achieve positive outcomes in the early postoperative period. Therefore, this study further supports the need for additional prospective, randomized-controlled trials, including preventive approaches for the development of acute renal failure on cardiac surgical populations, specifically children under the age of three years.
